| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Frederick William McNabb III is Director at UNH and has filed Form 4s across 2 companies. Frederick William McNabb III's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.8M at current prices.
The biggest single holding is UNH (~$6.4M) as Director. Net of sales, the UNH filings show accumulation of 6,519 shares.
Frederick William McNabb III has 99 Form 4 filings on record from April 2018 to October 2026, across 2 companies: Director at UnitedHealth Group (UNH), 2018–2026; Director at International Business Machines (IBM), 2019–2026.
The 100 reported transactions were 69 stock awards, 28 option or other derivative awards and 3 open-market purchases.
Counted by filing, the open-market trades come to 3 purchases worth about $2.5M and no sales.
The largest open-market purchase was 6,430 shares of UNH at an average $233.21 on May 1, 2019, about $1.5M.